FDA inspection
Altaire Pharmaceuticals, Inc.: FDA inspection ending Apr 19, 2019
FDA inspection 1089315 · Official Action Indicated (OAI) · Aquebogue, NY
Key facts
| Inspection ID | 1089315 |
|---|---|
| Firm | Altaire Pharmaceuticals, Inc. |
| FEI number | 1000119582 |
| Address | 311 W Ln |
| City | Aquebogue |
| State | NY |
| ZIP | 11931 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Apr 19, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 586153 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data